Lymphatica Medtech raises €17.9M Series B round

8 October 2024· Lausanne, Switzerland· health, medical_devices, biotech, b2b, software_hardware, deep_hardware

The investment will accelerate the clinical development and validation of LymphoDrain and support the opening of a subsidiary in Italy to manage R&D, manufacturing, and clinical operations

Investors

LeadPanakès Partners
Also participating
High-Tech GründerfondsCDP Venture CapitalZürcher KantonalbankOCCIDENTClub degli InvestitoriTechWald Next S.p.A.

About Lymphatica Medtech

Stage
Series B
Headquarters
Lausanne, Switzerland
Founded
2017
Team Size
21–50
Sectors
healthmedical_devicesbiotechb2bsoftware_hardwaredeep_hardware

Source: https://www.finsmes.com/2024/10/lymphatica-medtech-closes-e17-9m-series-b-funding.html